Top Markets
Coin of the day
BIOLASE, Inc. BIOLASE, Inc.

BIOLASE, Inc.

BIOL
Rank in Stocks #42643
BIOLASE, Inc., along with its various divisions, operates as a global... BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.
Share Price
$0.00695
Last synced: 2024-10-29
Market Cap
$536.40
Change (1 day)
-0.71%
Change (1 year)
0.00%
Country
US
Trade BIOLASE, Inc. (BIOL)

Category

P/B ratio for BIOLASE, Inc. (BIOL)
P/B ratio as of August 2026 TTM: -0.10
According to BIOLASE, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is -0.10. At the end of 2022 the company had a P/B ratio of 0.92.
P/B ratio history for BIOLASE, Inc. from 2000 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) -0.10 -98.22%
2023 -5.80 -728.93%
2022 0.92 -59.69%
2021 2.29 -10.73%
2020 2.56 -92.44%
2019 33.85 1,741.55%
2018 1.84 69.59%
2017 1.08 -71.84%
2016 3.85 96.28%
2015 1.96 -30.30%
2014 2.81 -75.72%
2013 11.59 120.47%
2012 5.26 -17.68%
2011 6.38 -142.09%
2010 -15.17 -342.77%
2009 6.25 52.49%
2008 4.10 12.38%
2007 3.65 -63.50%
2006 9.99 8.10%
2005 9.24 16.63%
2004 7.92 -32.36%
2003 11.71 -48.01%
2002 22.53 -70.00%
2001 75.09 129.62%
2000 32.70 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
3.6048 -3,582.90%
US
5.207 -5,130.92%
US
2.0146 -2,046.47%
IE
2.6697 -2,679.42%
US
4.8038 -4,741.35%
US